Naohiko Inase
Hiratsuka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Nationwide retrospective observational study of idiopathic dendriform pulmonary ossification: clinical features with a progressive phenotype.
Journal: BMJ open respiratory research
Published: June 20, 2022
Effects of nintedanib on disease progression and safety in Japanese patients with progressive fibrosing interstitial lung diseases: Further subset analysis from the whole INBUILD trial.
Journal: Respiratory investigation
Published: March 04, 2022
A phase II feasibility study of carboplatin and nab-paclitaxel for advanced non-small cell lung cancer patients with interstitial lung disease (YLOG0114).
Journal: Thoracic cancer
Published: December 13, 2021
Hypersensitivity pneumonitis: Acute, chronic nonfibrotic, and chronic fibrotic.
Journal: Respiratory investigation
Published: September 09, 2021
Efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD trial.
Journal: Respiratory medicine
Published: March 04, 2021
Safety and tolerability of combination therapy with pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A multicenter retrospective observational study in Japan.
Journal: Respiratory investigation
Published: December 22, 2020
Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Panel Report.
Journal: Chest
Published: November 03, 2020
Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias.
Journal: Thorax
Published: September 28, 2020
Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56.
Journal: The American journal of surgical pathology
Published: March 03, 2020
Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial.
Journal: The European respiratory journal
Published: February 18, 2020
A modified GAP model for East-Asian populations with idiopathic pulmonary fibrosis.
Journal: Respiratory investigation
Published: December 18, 2019
Last Updated: 09/26/2026